These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 30309848)

  • 21. Hyper-IgE syndrome, 2021 update.
    Minegishi Y
    Allergol Int; 2021 Oct; 70(4):407-414. PubMed ID: 34419355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T
    Stepensky P; Keller B; Shamriz O; von Spee-Mayer C; Friedmann D; Shadur B; Unger S; Fuchs S; NaserEddin A; Rumman N; Amro S; Molho Pessach V; Abuzaitoun O; Somech R; Elpeleg O; Ehl S; Warnatz K
    J Clin Immunol; 2018 May; 38(4):527-536. PubMed ID: 29948574
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Park B; Liu GY
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33271763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome.
    Woellner C; Gertz EM; Schäffer AA; Lagos M; Perro M; Glocker EO; Pietrogrande MC; Cossu F; Franco JL; Matamoros N; Pietrucha B; Heropolitańska-Pliszka E; Yeganeh M; Moin M; Español T; Ehl S; Gennery AR; Abinun M; Breborowicz A; Niehues T; Kilic SS; Junker A; Turvey SE; Plebani A; Sánchez B; Garty BZ; Pignata C; Cancrini C; Litzman J; Sanal O; Baumann U; Bacchetta R; Hsu AP; Davis JN; Hammarström L; Davies EG; Eren E; Arkwright PD; Moilanen JS; Viemann D; Khan S; Maródi L; Cant AJ; Freeman AF; Puck JM; Holland SM; Grimbacher B
    J Allergy Clin Immunol; 2010 Feb; 125(2):424-432.e8. PubMed ID: 20159255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Profile of Hyper-IgE Syndrome in India.
    Saikia B; Rawat A; Minz RW; Suri D; Pandiarajan V; Jindal A; Sahu S; Karim A; Desai M; Taur PD; Pandrowala A; Gowri V; Madkaikar M; Dalvi A; Yadav RM; Lashkari HP; Raj R; Uppuluri R; Swaminathan VV; Bhattad S; Cyril G; Kumar H; Shukla A; Kalra M; Govindaraj G; Singh S
    Front Immunol; 2021; 12():626593. PubMed ID: 33717144
    [No Abstract]   [Full Text] [Related]  

  • 26. Key findings to expedite the diagnosis of hyper-IgE syndromes in infants and young children.
    Hagl B; Heinz V; Schlesinger A; Spielberger BD; Sawalle-Belohradsky J; Senn-Rauh M; Magg T; Boos AC; Hönig M; Schwarz K; Dückers G; von Bernuth H; Pache C; Karitnig-Weiss C; Belohradsky BH; Frank J; Niehues T; Wahn V; Albert MH; Wollenberg A; Jansson AF; Renner ED
    Pediatr Allergy Immunol; 2016 Mar; 27(2):177-84. PubMed ID: 26592211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyper IgE syndromes: clinical and molecular characteristics.
    Al-Shaikhly T; Ochs HD
    Immunol Cell Biol; 2019 Apr; 97(4):368-379. PubMed ID: 30264496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome.
    Milner JD; Brenchley JM; Laurence A; Freeman AF; Hill BJ; Elias KM; Kanno Y; Spalding C; Elloumi HZ; Paulson ML; Davis J; Hsu A; Asher AI; O'Shea J; Holland SM; Paul WE; Douek DC
    Nature; 2008 Apr; 452(7188):773-6. PubMed ID: 18337720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel STAT3 mutation associated with hyper immunoglobulin E syndrome with a paucity of connective tissue signs.
    Yoshida Y; Nagamori T; Takahashi H; Ishibazawa E; Shimada S; Kawai T; Azuma H
    Pediatr Int; 2021 May; 63(5):510-515. PubMed ID: 32920916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The hyperimmunoglobulin E syndrome--clinical manifestation diversity in primary immune deficiency.
    Szczawinska-Poplonyk A; Kycler Z; Pietrucha B; Heropolitanska-Pliszka E; Breborowicz A; Gerreth K
    Orphanet J Rare Dis; 2011 Nov; 6():76. PubMed ID: 22085750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokine and chemokine dysregulation in hyper-IgE syndrome.
    Chehimi J; Elder M; Greene J; Noroski L; Stiehm ER; Winkelstein JA; Sullivan KE
    Clin Immunol; 2001 Jul; 100(1):49-56. PubMed ID: 11414745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoimmune arthritis associated with mutated interleukin (IL)-6 receptor gp130 is driven by STAT3/IL-7-dependent homeostatic proliferation of CD4+ T cells.
    Sawa S; Kamimura D; Jin GH; Morikawa H; Kamon H; Nishihara M; Ishihara K; Murakami M; Hirano T
    J Exp Med; 2006 Jun; 203(6):1459-70. PubMed ID: 16717113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
    Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
    Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical manifestations of hyper IgE syndromes.
    Freeman AF; Holland SM
    Dis Markers; 2010; 29(3-4):123-30. PubMed ID: 21178271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low incidence of IL6ST (gp130) mutations in exon 6 in lung cancer of a Chinese cohort.
    Sun L; Sui L; Cong X; Ma K; Ma X; Huang Y; Fan C; Fu X; Ma K
    Cancer Genet; 2014; 207(7-8):291-8. PubMed ID: 25242236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clearance of atypical cutaneous manifestations of hyper-IgE syndrome with dupilumab.
    Nihal A; Comstock JR; Holland KE; Singh AM; Seroogy CM; Arkin LM
    Pediatr Dermatol; 2022 Nov; 39(6):940-942. PubMed ID: 35734823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human TYK2 deficiency: Mycobacterial and viral infections without hyper-IgE syndrome.
    Kreins AY; Ciancanelli MJ; Okada S; Kong XF; Ramírez-Alejo N; Kilic SS; El Baghdadi J; Nonoyama S; Mahdaviani SA; Ailal F; Bousfiha A; Mansouri D; Nievas E; Ma CS; Rao G; Bernasconi A; Sun Kuehn H; Niemela J; Stoddard J; Deveau P; Cobat A; El Azbaoui S; Sabri A; Lim CK; Sundin M; Avery DT; Halwani R; Grant AV; Boisson B; Bogunovic D; Itan Y; Moncada-Velez M; Martinez-Barricarte R; Migaud M; Deswarte C; Alsina L; Kotlarz D; Klein C; Muller-Fleckenstein I; Fleckenstein B; Cormier-Daire V; Rose-John S; Picard C; Hammarstrom L; Puel A; Al-Muhsen S; Abel L; Chaussabel D; Rosenzweig SD; Minegishi Y; Tangye SG; Bustamante J; Casanova JL; Boisson-Dupuis S
    J Exp Med; 2015 Sep; 212(10):1641-62. PubMed ID: 26304966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomic Multiple Sclerosis Risk Variants Modulate the Expression of the
    Mena J; Alloza I; Tulloch Navarro R; Aldekoa A; Díez García J; Villanueva Etxebarria A; Lindskog C; Antigüedad A; Boyero S; Mendibe-Bilbao MDM; Álvarez de Arcaya A; Sánchez Menoyo JL; Midaglia L; Villarrubia N; Malhotra S; Montalban X; Villar LM; Comabella M; Vandenbroeck K
    Front Immunol; 2021; 12():816930. PubMed ID: 35111166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deficient T Cell Receptor Excision Circles (TRECs) in autosomal recessive hyper IgE syndrome caused by DOCK8 mutation: implications for pathogenesis and potential detection by newborn screening.
    Dasouki M; Okonkwo KC; Ray A; Folmsbeel CK; Gozales D; Keles S; Puck JM; Chatila T
    Clin Immunol; 2011 Nov; 141(2):128-32. PubMed ID: 21763205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IgE, CD8(+)CD60+ T cells and IFN-alpha in human immunity to parvovirus B19 in selective IgA deficiency.
    Bluth MH; Norowitz KB; Chice S; Shah VN; Nowakowski M; Durkin HG; Smith-Norowitz TA
    Hum Immunol; 2005 Oct; 66(10):1029-38. PubMed ID: 16386644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.